- Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey
2026Autoimmunity ReviewsJournalOpen access0 citations10.1016/j.autrev.2026.104172
- Social media landscape: a cross-sectional survey of health professionals
2025Rheumatology InternationalJournalOpen access1 citations10.1007/s00296-025-06000-4
- The Evolving Digital Landscape of Social Media among Rheumatology Professionals: Results of the EULAR SoMeR Study Group Survey
2025AMJ RheumatologyJournalOpen accessSenior author0 citations10.33590/rheumatolamj/ugxj1610
- Global social media use among rheumatology professionals: the EULAR SoMeR Study Group survey
2025RMD OpenJournalOpen accessSenior author0 citations10.1136/rmdopen-2025-006179
- Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
2025University of Debrecen Electronic Archive (University of Debrecen)JournalOpen accessCorresponding0 citations10.1093/rap/rkae154/7934280
- Characteristics of emerging new autoimmune diseases after COVID ‐19 vaccination: A sub‐study by the COVAD group
2024International Journal of Rheumatic DiseasesJournalOpen access8 citations10.1111/1756-185x.15178
- The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset
2024Lara D. VeekenJournalOpen access6 citations10.1093/rheumatology/keae520
- Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology
2024Rheumatology Advances in PracticeJournalOpen access4 citations10.1093/rap/rkae021
- Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
2024Rheumatology Advances in PracticeJournalOpen access6 citations10.1093/rap/rkae028
- Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
2024Rheumatology InternationalJournalOpen access4 citations10.1007/s00296-024-05562-z
- Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges
2024International Journal of Rheumatic DiseasesJournalOpen access3 citations10.1111/1756-185x.15161
- Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
2024Rheumatology InternationalJournalOpen access1 citations10.1007/s00296-024-05682-6
- Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
2024Rheumatology Advances in PracticeJournalOpen accessCorresponding1 citations10.1093/rap/rkae154
- Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
2024Lara D. VeekenJournalOpen access1 citations10.1093/rheumatology/keae128
- COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey
2024Rheumatology InternationalJournalOpen accessCorresponding1 citations10.1007/s00296-024-05742-x
- Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
2024University of Debrecen Electronic Archive (University of Debrecen)JournalOpen access0 citations10.1093/rap/rkae028/7619044
- Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
2023Lara D. VeekenJournalOpen access35 citations10.1093/rheumatology/kead144
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
2023Lara D. VeekenJournalOpen access18 citations10.1093/rheumatology/kead057
- Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
2023Lara D. VeekenJournalOpen access10 citations10.1093/rheumatology/kead180
- Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study
2023Rheumatology InternationalJournalOpen access10 citations10.1007/s00296-023-05345-y
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
2023Lara D. VeekenJournalOpen access8 citations10.1093/rheumatology/kead149
- Flares of autoimmune rheumatic disease following COVID ‐19 infection: Observations from the COVAD study
2023International Journal of Rheumatic DiseasesJournalOpen access7 citations10.1111/1756-185x.14961
- COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
2023Journal of Clinical MedicineJournalOpen access4 citations10.3390/jcm12247542
- COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
2023Lara D. VeekenJournalOpen access4 citations10.1093/rheumatology/kead382
- Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort
2023Rheumatology InternationalJournalOpen access3 citations10.1007/s00296-023-05441-z
- POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY
2023Annals of the Rheumatic DiseasesJournalOpen access1 citations10.1136/annrheumdis-2023-eular.4241
- LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study
2023PublicationOpen access0 citations10.1136/lupus-2023-kcr.19
- COVAD survey 2 long-term outcomes: unmet need and protocol
2022Rheumatology InternationalJournalOpen access44 citations10.1007/s00296-022-05157-6